Literature DB >> 26775603

Challenges in the management of recurrent endometrial cancer.

Peng-Hui Wang1, Kuo-Chang Wen2, Ming-Shyen Yen2.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 26775603     DOI: 10.1016/j.jcma.2015.11.005

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


× No keyword cloud information.
  4 in total

1.  MR- versus CT-based high-dose-rate interstitial brachytherapy for vaginal recurrence of endometrial cancer.

Authors:  Sophia C Kamran; Matthias M Manuel; Paul Catalano; Linda Cho; Antonio L Damato; Larissa J Lee; Ehud J Schmidt; Akila N Viswanathan
Journal:  Brachytherapy       Date:  2017-08-17       Impact factor: 2.362

2.  Outcomes of Patients With Surgically and Pathologically Staged IIIA-IVB Pure Endometrioid-type Endometrial Cancer: A Taiwanese Gynecology Oncology Group (TGOG-2005) Retrospective Cohort Study (A STROBE-Compliant Article).

Authors:  Jen-Ruei Chen; Ting-Chang Chang; Hung-Chun Fu; Hei-Yu Lau; I-Hui Chen; Yu-Min Ke; Yu-Ling Liang; An-Jen Chiang; Chia-Yen Huang; Yu-Chieh Chen; Mun-Kun Hong; Yu-Chi Wang; Kuo-Feng Huang; Sheng-Mou Hsiao; Peng-Hui Wang
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

3.  Recurrence Features and Factors influencing Post-relapse Survival in Early-stage Endometrial Cancer after Adjuvant Radiotherapy.

Authors:  Kang Ren; Wenhui Wang; Shuai Sun; Dunhuang Wang; Xiaoliang Liu; Xiaorong Hou; Ke Hu; Fuquan Zhang
Journal:  J Cancer       Date:  2022-01-01       Impact factor: 4.207

Review 4.  Endometrial stromal sarcoma in combination with mixed type endometrial carcinomas: A case report and literature review.

Authors:  Xiao-Xin Xiu; Hua-Li Wang; Lv Yun-Yi; Kong Fan-Dou; Hou Jin-Ping
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.